Causal claim

Fda Regulatory U Turn Uniqure

Fda Regulatory U Turn enables Uniqure.

The two move together: more cause, more effect. The map scores it at 30% confidence, weighed from 1 article.

How it works

Regulatory reversal reopens pathway for uniQure to refile its BLA for its previously rejected gene therapy

The evidence

Where it sits

What feeds it

Nothing upstream on the map yet.

See it on the live map →